Target intelligence / Profile preview

Urea transporters and aquaporins (Urea transporter (UT, specific isoforms include UT-A and UT-B); Aquaporin (AQP, specific isoforms include AQP1–AQP12))

Target
Urea transporter (UT, specific isoforms include UT-A and UT-B); Aquaporin (AQP, specific isoforms include AQP1–AQP12)
Molecular classification
Transporter, Channel-like transporter, SLC (solute carrier) family, SLC14A1 (for UT-B), SLC14A2 (for UT-A), Water channel, MIP (major intrinsic protein) family, Aquaglyceroporin subgroup (for AQP3, 7, 9, 10)
01

Overview

Urea transporters are membrane proteins that facilitate the rapid, selective transport of urea across cell membranes along its concentration gradient. They are crucial for urine concentration in the kidney and are highly expressed in tissues like erythrocytes and renal medulla[7][8][9]. Two main types in mammals are UT-A (several isoforms, kidney-specific) and UT-B (erythrocytes, various tissues)[8][9][7]. Aquaporins are a diverse family of small, membrane-spanning water channels (AQP0–AQP12) that enable rapid and selective movement of water (and in some subfamilies, small solutes including glycerol and urea) across membranes[1][2][3][6][7]. These channels are critical for water homeostasis in organs such as the kidney, brain, eye, and secretory glands. Aquaglyceroporins (AQP3, 7, 9, and 10) can also transport urea and glycerol, which are important in energy metabolism and epidermal hydration[2][3][6][7]. Both families share similar roles in regulating osmotic balance but differ structurally and in substrate specificity; some AQPs have overlapping functions with UTs in urea transport, but the protein families are genetically and structurally distinct[7]. Disruption or dysregulation of either can contribute to a range of pathophysiological states, making them therapeutic targets for kidney disease, metabolic disorders, neuroinflammation, and cancer[3][6][9][1][7].

Other names
UTSLC14A familyUT-AUT-BAQPwater channelaquaglyceroporin
02

Mechanism of action

Inhibition of urea channels to limit renal concentration of urea, affecting urine concentration/pharmacokinetics; Inhibition/modulation of aquaporin-mediated water transport to address conditions of water imbalance; Possible modulation of CO₂/ammonia transport (future directions)

03

Biological functions

Regulation of water homeostasisRegulation of urea transport (especially in kidney, erythrocyte, and other tissues)Osmotic balance and urine concentrationEnergy metabolism and epidermal hydration (glycerol, urea transport)Acid–base homeostasis (CO₂, ammonia transport by some AQPs)Saliva excretion, absorption in adipose tissue
04

Disease associations

Water-electrolyte imbalance (especially in kidney and brain)Neurological/neuroinflammatory diseasesCancer (overexpression, dysfunction)Obesity and metabolic syndromesCardiovascular disease (blood pressure regulation)
05

Safety considerations

Potential for disturbances in water and electrolyte homeostasis if inhibited or dysregulatedChallenges in selective targeting due to widespread tissue expression; risk for off-target effectsLimited druggability of aquaporin channels using small molecules at present
06

Interacting drugs

phloretin

3 more in the full profile.

07

Biomarkers

Expression levels of specific urea transporter isoforms (e.g., UT-B in erythrocytes or kidneys)Aquaporin isoforms (e.g., AQP2 in kidney disease, AQP4 in brain)

Beyond the preview

Go deeper on Urea transporters and aquaporins (Urea transporter (UT, specific isoforms include UT-A and UT-B); Aquaporin (AQP, specific isoforms include AQP1–AQP12)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urea transporters and aquaporins (Urea transporter (UT, specific isoforms include UT-A and UT-B); Aquaporin (AQP, specific isoforms include AQP1–AQP12)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call